News › Industry News, Patient Care

The state of off-label drug laws

October 31, 2018

Prescribing drugs off label can sometimes be the best option for patients. It’s an unavoidable part of medicine. Some of the most important discoveries have been accidental discoveries in which a patient has benefited from an off-label use of a drug.
Currently, federal law allows manufacturers to respond to unsolicited questions from physicians, share peer-reviewed articles and sponsor continuing medical education courses. Congress has proposed two bills that are designed to expand those rules.
Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
    • Galderma Receives EU Approval for Restylane Shaype: Bone-Mimicking Hyaluronic Acid Injectable for Chin
    • Merz Aesthetics’ Ultherapy PRIME Gains FDA Clearance for Knee Skin Laxity
    • USA Payments Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Accepts Supplemental Biologics License Application for Botox Cosmetic for Masseter Muscle Prominence
Advertisement